🇺🇸 FDA
Patent

US 11548940

Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

granted A61KA61K2039/542A61K38/26

Quick answer

US patent 11548940 (Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device) held by Rani Therapeutics, LLC expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K2039/542, A61K38/26, A61K38/28, A61K39/00114